These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 8503562)
1. Changes in cell population and tumor necrosis factor, interleukin-6, and interleukin-8 in malignant pleural effusions after treatment with intrapleural tetracycline. Lin CC; Liu CC; Lin CY Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1503-6. PubMed ID: 8503562 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of ferritin, interleukin-6, interleukin-8 and tumor necrosis factor alpha in the differentiation of exudates and transudates in pleural effusions. Alexandrakis MG; Coulocheri SA; Bouros D; Eliopoulos GD Anticancer Res; 1999; 19(4C):3607-12. PubMed ID: 10629659 [TBL] [Abstract][Full Text] [Related]
3. Cytokines and soluble cytokine receptors in pleural effusions from septic and nonseptic patients. Marie C; Losser MR; Fitting C; Kermarrec N; Payen D; Cavaillon JM Am J Respir Crit Care Med; 1997 Nov; 156(5):1515-22. PubMed ID: 9372669 [TBL] [Abstract][Full Text] [Related]
4. Effect of repeated thoracenteses on fluid characteristics, cytokines, and fibrinolytic activity in malignant pleural effusion. Chung CL; Chen YC; Chang SC Chest; 2003 Apr; 123(4):1188-95. PubMed ID: 12684310 [TBL] [Abstract][Full Text] [Related]
5. IL-8 in pleural effusion. Ceyhan BB; Ozgün S; Celikel T; Yalçin M; Koç M Respir Med; 1996 Apr; 90(4):215-21. PubMed ID: 8736655 [TBL] [Abstract][Full Text] [Related]
6. OK-432 induces production of neutrophil chemotactic factors in malignant pleural effusion. Kataoka M; Morishita R; Hiramatsu J; Ueoka H; Nakata Y; Ohnoshi T; Kimura I; Harada M Intern Med; 1995 May; 34(5):352-6. PubMed ID: 7647401 [TBL] [Abstract][Full Text] [Related]
7. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions. Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-16 in tuberculous and malignant pleural effusions. Qin XJ; Shi HZ; Huang ZX; Kang LF; Mo WN; Wu C Eur Respir J; 2005 Apr; 25(4):605-11. PubMed ID: 15802332 [TBL] [Abstract][Full Text] [Related]
9. Immunological status of patients subjected to cardiac surgery: serum levels of interleukin 6 and tumor necrosis factor alpha and the ability of peripheral blood mononuclear cells to proliferate and produce these cytokines in vitro. Właszczyk A; Adamik B; Durek G; Kübler A; Zimecki M Arch Immunol Ther Exp (Warsz); 1996; 44(4):225-34. PubMed ID: 9017162 [TBL] [Abstract][Full Text] [Related]
10. Acute phase markers for the differentiation of infectious and malignant pleural effusions. Kiropoulos TS; Kostikas K; Oikonomidi S; Tsilioni I; Nikoulis D; Germenis A; Gourgoulianis KI Respir Med; 2007 May; 101(5):910-8. PubMed ID: 17270413 [TBL] [Abstract][Full Text] [Related]
11. Tumor-associated lymphocytes (TAL) are competent to produce higher levels of cytokines in neoplastic pleural and peritoneal effusions than those found in sera and are able to release into culture higher levels of IL-2 and IL-6 than those released by PBMC. Mantovani G; Macciò A; Versace R; Pisano M; Lai P; Esu S; Ghiani M; Dessì D; Turnu E; Santona MC J Mol Med (Berl); 1995 Aug; 73(8):409-16. PubMed ID: 8528743 [TBL] [Abstract][Full Text] [Related]
12. IL-6 in malignant pleural effusions and its augmentation by intrapleural instillation of IL-2. Yanagawa H; Sone S; Munekata M; Atagi S; Nii A; Ogura T Clin Exp Immunol; 1992 May; 88(2):207-12. PubMed ID: 1315227 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-8 is a major neutrophil chemotactic factor in pleural liquid of patients with empyema. Broaddus VC; Hébert CA; Vitangcol RV; Hoeffel JM; Bernstein MS; Boylan AM Am Rev Respir Dis; 1992 Oct; 146(4):825-30. PubMed ID: 1416405 [TBL] [Abstract][Full Text] [Related]
14. [Values of TNF, IL-8, sICAM-1 and CD11b/CD18 in benign and malignant pleural effusions]. Huang Y; Xie C Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jan; 24(1):35-9. PubMed ID: 11802937 [TBL] [Abstract][Full Text] [Related]
15. [Induction by local injections of IL-2 of antitumor effector cells and secondary production of cytokines in malignant pleural effusion]. Sone S; Yanagawa H; Nii A; Ozaki T; Ogura T Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Aug; 30(8):1434-40. PubMed ID: 1434216 [TBL] [Abstract][Full Text] [Related]
16. Tumour necrosis factor-alpha and nitric oxide, determined as nitrite, in malignant pleural effusion. Agrenius V; Gustafsson LE; Widström O Respir Med; 1994 Nov; 88(10):743-8. PubMed ID: 7846335 [TBL] [Abstract][Full Text] [Related]
17. [Colony-stimulating factor activity in malignant pleural effusions and its augmentation by local administration of interleukin 2]. Nakanishi M; Sone S; Ogura T Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Jul; 29(7):824-8. PubMed ID: 1920977 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of interleukine-6, transforming growth factor-beta 1 and vascular endothelial growth factor in malignant pleural effusions. Duysinx BC; Corhay JL; Hubin L; Nguyen D; Henket M; Louis R Respir Med; 2008 Dec; 102(12):1708-14. PubMed ID: 18760578 [TBL] [Abstract][Full Text] [Related]
19. Recruitment of inflammatory cells to the pleural space. Chemotactic cytokines, IL-8, and monocyte chemotactic peptide-1 in human pleural fluids. Antony VB; Godbey SW; Kunkel SL; Hott JW; Hartman DL; Burdick MD; Strieter RM J Immunol; 1993 Dec; 151(12):7216-23. PubMed ID: 8258721 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-8 induces lymphocyte chemotaxis into the pleural space. Role of pleural macrophages. Pace E; Gjomarkaj M; Melis M; Profita M; Spatafora M; Vignola AM; Bonsignore G; Mody CH Am J Respir Crit Care Med; 1999 May; 159(5 Pt 1):1592-9. PubMed ID: 10228132 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]